Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cholinergic receptor nicotinic alpha 3 subunit | 0.588 | 0.692 | 1.4E-07 |
|
phenotype | 0.100 | None | 1.000 | 5 | 3 | 2008 | 2017 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2010 | 2019 | ||||||||
|
BDNF antisense RNA | 0.638 | 0.538 |
|
phenotype | 0.100 | None | 1.000 | 3 | 2 | 2010 | 2019 | |||||||||
|
FPGT-TNNI3K readthrough | 0.890 | 0.154 | 3.2E-48 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2017 | 2019 | ||||||||
|
IKAROS family zinc finger 4 | 0.861 | 0.192 | 0.90 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2015 | 2019 | ||||||||
|
long intergenic non-protein coding RNA 1505 | 0.821 | 0.192 |
|
phenotype | 0.100 | None | 1.000 | 2 | 3 | 2017 | 2019 | |||||||||
|
BBX high mobility group box domain containing | 0.839 | 0.231 | 0.52 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2009 | 2017 | ||||||||
|
hydroxylysine kinase | 0.769 | 0.346 | 7.3E-06 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2015 | 2017 | ||||||||
|
contactin associated protein family member 4 | 0.839 | 0.192 | 7.8E-07 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2015 | 2019 | ||||||||
|
mitogen-activated protein kinase kinase 5 | 0.628 | 0.654 | 4.8E-03 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2017 | 2019 | ||||||||
|
TNNI3 interacting kinase | 0.691 | 0.346 | 3.1E-48 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2017 | 2019 | ||||||||
|
leucine rich repeat and Ig domain containing 2 | 0.674 | 0.615 | 0.86 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2015 | 2017 | ||||||||
|
cytochrome P450 family 2 subfamily F member 2, pseudogene |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2018 | |||||||||||
|
citrate lyase beta like | 0.743 | 0.500 | 1.6E-09 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2015 | 2019 | ||||||||
|
cell adhesion molecule 2 | 0.670 | 0.538 | 0.89 |
|
phenotype | 0.100 | None | 1.000 | 2 | 3 | 2017 | 2019 | ||||||||
|
cholinergic receptor nicotinic alpha 4 subunit | 0.492 | 0.808 | 8.5E-05 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2015 | 2018 | ||||||||
|
thrombospondin type 1 domain containing 7B | 0.890 | 0.154 | 2.6E-19 |
|
phenotype | 0.100 | None | 1.000 | 2 | 3 | 2015 | 2019 | ||||||||
|
calcium voltage-gated channel auxiliary subunit alpha2delta 3 | 0.711 | 0.577 | 0.58 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
ArfGAP with dual PH domains 2 | 0.839 | 0.308 | 4.2E-10 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
ER membrane protein complex subunit 3 | 0.805 | 0.308 | 0.29 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
PIN2 (TERF1) interacting telomerase inhibitor 1 | 0.587 | 0.692 | 4.6E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
calcium/calmodulin dependent protein kinase ID | 0.743 | 0.423 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
glutaminyl-peptide cyclotransferase like | 0.805 | 0.346 | 1.6E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
phosphotyrosine interaction domain containing 1 | 0.700 | 0.231 | 3.1E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
hedgehog acyltransferase | 0.608 | 0.577 | 3.2E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 |